Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,004.9
4.9 (0.16%)

 

  • STI Straits Times Index
    3,004.9
    4.9 (0.16%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,627.0
    -8.7 (-0.53%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    28,573.9
    77.0 (0.27%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,566.4
    0.5 (0.01%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    28,519.2
    -179.1 (-0.62%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,373.4
    -54.9 (-0.85%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 3,982.9M
  • Value: 1,509.5M
  • Rise: 218
  • Fall: 137
  • Unch: 425

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Incredible R0.001-
Jiutian Chemical0.100+0.002
Oceanus^0.038+0.002
DISA0.002-
AusGroup0.032-
The Place Hldg0.051+0.003
Sembcorp Marine0.169-
CWX Global0.003-0.001
Advanced Systems0.001-
MarcoPolo Marine0.017+0.001

World Indices

World Indices
Name Last Change
Nasdaq 12,998.5 -114.1
HSI 28,573.9 +77.0
HSCEI 11,320.5 +21.4
Jakarta 6,373.4 -54.9
Nikkei 225 28,519.2 -179.1
SSE Comp 3,566.4 +0.5
Shanghai A 3,738.3 +0.5
Shanghai B 250.7 +0.2
KOSPI 3,085.9 -64.0

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

Medtecs Intl MEDTECS INTERNATIONAL CORP LTD
Quotes 10 Minutes Delayed. Updated at 15 Jan 2021 17:14
Last (SGD): 1.120 Change: +0.020 High: 1.140 Remarks: -
Change (%): +1.82 Low: 1.110
Open 1.130 Yesterday's Close 1.100
Buy Price 1.110 Sell Price 1.120
Buy Volume ('000) 961.9 Sell Volume ('000) 193.1
Cumulative Volume ('000) 8,023.6 Cumulative Value 9,017,366
Click to show Stock Prices chart

Key Statistics

EPS (SGD) a 0.00285 Trailing EPS (SGD) e 0.10052 NAV (SGD) b 0.2571
PE a 392.982 Trailing PE f 11.142 Price / NAV b 4.3563
Dividend (SGD) d - Cash In Hand (SGD) g 0.0525 Issued & Paid-up Shares c 549,411,000
Dividend Yield (%) d - Price / Cash In Hand g 21.333 Treasury Shares h -
Beta - 75 Daysi -0.333 R-Squared - 75 Days(%)i 0.67 Market Cap (M) 615.340
Beta - 500 Daysi -0.160 R-Squared - 500 Days (%)i 0.04 Enterprise Value (M) 643.043
Piotroski F Score 7 Exchange Code 546 Par Value ( USD ) 0.05000
52 Weeks Volatility (%) 150.8298 6-Month VWAP 1.170 Free Float (%) 99.7
Under CPF Investment Scheme (CPFIS) No
Sector & Industry Manufacturing - Medical Specialties
Category Classification Medical & Biotechnology
Index Components FTSE ST Catalist Index
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 23 Dec 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand.
  9. Beta and R-Squared are calculated in relation to the market index (STI or KLCI) using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference Medtecs Intl SGX 615.340 392.982 11.142 4.3563 -
Industry Medical & Biotechnology SGX 942.803 23.157 21.779 1.3769 1.962
Medical Specialties SGX 3,017.185 29.512 12.803 8.7150 1.737
Index FTSE ST Catalist Index SGX 57.369 30.063 88.683 1.3725 1.229
Local Peer Top Glove SGX 16,927.960 27.881 12.527 9.2993 1.850
Local Peer UGHealthcare SGX 443.706 33.103 33.107 6.2230 0.316
Local Peer Biolidics SGX 83.175 - - 7.7206 -
Local Peer Annica SGX 16.675 - - 5.0000 -
Local Peer Yunnan Energy SGX 16.251 - - 0.3360 -
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 199,411.992 53.953 40.871 6.2661 0.152
Global Peer ABBOTT LABORATORIES NYSE 197,263.668 53.809 58.973 6.2851 1.179
Global Peer DANAHER CORP NYSE 168,181.755 67.575 53.989 4.8477 0.281
Global Peer MEDTRONIC PLC NYSE 157,228.596 32.831 44.453 3.1343 1.911
Global Peer INTUITIVE SURGICAL INC NASDAQ 91,507.163 66.343 86.893 9.8843 -
Global Peer STRYKER CORP NYSE 90,937.664 43.657 51.787 7.0028 0.879
Global Peer BECTON DICKINSON & CO NYSE 76,127.602 99.254 99.254 3.2036 1.204
Global Peer EDWARDS LIFESCIENCES CORP NYSE 54,764.802 52.311 68.965 13.0074 -
Global Peer BOSTON SCIENTIFIC CORP NYSE 52,021.654 11.068 14.117 3.3424 -
Global Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 49,397.294 37.818 44.335 4.0158 1.687
Other Global Peers ALIGN TECHNOLOGY INC (NASDAQ), IDEXX LABORATORIES INC (NASDAQ), BAXTER INTERNATIONAL INC (NYSE), AGILENT TECHNOLOGIES INC (NYSE), ALCON AG (NYSE), DEXCOM INC (NASDAQ), ZIMMER BIOMET HOLDINGS INC (NYSE), RESMED INC (NYSE), GENMAB AS SPON ADS EACH REP 0.1 ORD SHS (NASDAQ), METTLER-TOLEDO INTERNATIONAL INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), HOLOGIC INC (NASDAQ), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), INSULET CORPORATION (NASDAQ), COOPER COS INC (NYSE), TELEFLEX INC (NYSE), BIO RAD LABORATORIES INC (NYSE), NOVOCURE LTD (NASDAQ), WATERS CORP (NYSE), PERKINELMER INC (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), STERIS PLC (NYSE), ABIOMED INC (NASDAQ), MASIMO CORPORATION (NASDAQ), FISHER & PAYKEL HEALTHCARE CORP (ASX), DENTSPLY SIRONA INC (NASDAQ), TOPGLOV (Bursa), QIAGEN NV (NYSE), MICROPORT (HKEx), HARTA (Bursa), COCHLEAR LTD (ASX), BRUKER CORPORATION (NASDAQ), WEIGAO GROUP (HKEx), QUIDEL CORP (NASDAQ), PENUMBRA INC (NYSE), IRHYTHM TECHNOLOGIES INC (NASDAQ), SOTERA HEALTH CO (NASDAQ), HILL-ROM HOLDINGS INC (NYSE), HAEMONETICS CORP (NYSE), GLOBUS MED INC (NYSE), NEVRO CORP (NYSE), ENVISTA HOLDINGS CORPORATION (NYSE), TANDEM DIABETES CARE INC (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), INSPIRE MEDICAL SYSTEMS INC (NYSE), SHOCKWAVE MEDICAL INC (NASDAQ), INARI MEDICAL INC (NASDAQ), ICU MEDICAL INC (NASDAQ), NEOGEN CORP (NASDAQ), CAREDX INC (NASDAQ), SUPERMX (Bursa), STAAR SURGICAL CO (NASDAQ), GLAUKOS CORPORATION (NYSE), VENUS MEDTECH-B (HKEx), EBOS GROUP (ASX), LIVANOVA PLC (NASDAQ), CONMED CORP (NYSE), CANTEL MEDICAL CORP (NYSE), MERIT MEDICAL SYSTEMS (NASDAQ), NUVASIVE INC (NASDAQ), ATRICURE INC (NASDAQ), LIFETECH SCI (HKEx), BIOTELEMETRY INC (NASDAQ), NANO-X IMAGING LTD (NASDAQ), AVANOS MEDICAL INC (NYSE), PEIJIA-B (HKEx), KANGJI MEDICAL (HKEx), PULMONX CORPORATION (NASDAQ), OUTSET MEDICAL INC (NASDAQ), EARGO INC (NASDAQ), INMODE LTD (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), AK MEDICAL (HKEx), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), VERICEL CORP (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), 908 DEVICES INC (NASDAQ), NANOSONICS LIMITED (ASX), HESKA CORP (NASDAQ), MESA LABORATORIES INC (NASDAQ), ATRION CORP (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), CERUS CORP (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), CIRC (HKEx), GENMARK DIAGNOSTICS INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), INOGEN INC (NASDAQ), CRYOLIFE INC (NYSE), DERMTECH INC (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), SI BONE INC (NASDAQ), CHUNLI MEDICAL (HKEx), NATUS MEDICAL INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), VAPOTHERM INC (NYSE), VIEWRAY INC (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), KDL MEDICAL (HKEx), INFUSYSTEM HOLDINGS INC (NYSE American), AXOGEN INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), ANTARES PHARMA INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), QUOTIENT LTD (NASDAQ), SURMODICS INC (NASDAQ), ZYNEX INC (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), CORMEDIX INC (NYSE American), AVITA THERAPEUTICS INC (NASDAQ), PROFOUND MED CORP (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), MCP INCOME OPPORTUNITIES TRUST (ASX), CUTERA INC (NASDAQ), MEDAVAIL HOLDINGS INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), CLEANSPACE HOLDINGS LTD (ASX), RETRACTABLE TECHNOLOGIES INC (NYSE American), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), CYTOSORBENTS CORP (NASDAQ), MEDICAL DEVELOPMENT INTL (ASX), YESTAR HEALTH (HKEx), STEREOTAXIS INC (NYSE American), APYX MEDICAL CORPORATION (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), INVACARE CORP (NYSE), UTAH MEDICAL PRODUCTS (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), IRADIMED CORP (NASDAQ), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), NEURONETICS INC (NASDAQ), AROA BIOSURGERY LTD (ASX), REPRO MEDSYSTEMS INC (NASDAQ), SIENTRA INC (NASDAQ), MISONIX INC (NASDAQ), TELA BIO INC (NASDAQ), SOLITON INC (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), CYCLOPHARM LIMITED (ASX), ALPHA PRO TECH (NYSE American), VINCENT MED (HKEx), KELFRED (HKEx), SURGALIGN HOLDINGS INC (NASDAQ), MODERN DENTAL (HKEx), SOLENO THERAPEUTICS INC (NASDAQ), EMVISION MEDICAL DEVICES LTD (ASX), INTRICOM CORP (NASDAQ), TITAN MEDICAL INC (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), IMAGION BIOSYSTEMS LIMITED (ASX), DARIOHEALTH CORP (NASDAQ), PAVMED INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), SOMNOMED LIMITED (ASX), INCANNEX HEALTHCARE LTD (ASX), ATOMO DIAGNOSTICS LIMITED (ASX), FONAR CORP (NASDAQ), IMPEDIMED LIMITED (ASX), AVINGER INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), VENUS CONCEPT INC (NASDAQ), PW MEDTECH (HKEx), ROCKWELL MEDICAL INC (NASDAQ), ONCOCYTE CORP (NYSE American), VOLITIONRX LIMITED (NYSE American), LKL (Bursa), CONFORMIS INC (NASDAQ), MICRO-X LTD (ASX), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), MILESTONE SCIENTIFIC INC (NYSE American), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), ELECTROMED INC (NYSE American), ELECTROCORE INC (NASDAQ), RESPIRI LTD (ASX), IRIDEX CORP (NASDAQ), CHECK-CAP LTD (NASDAQ), BIOLASE INC (NASDAQ), NEPHROS INC (NASDAQ), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), RESONANCE HEALTH LTD (ASX), BELLEROPHON THERAPEUTICS INC (NASDAQ), LENSAR INC (NASDAQ), SDI LTD (ASX), EKSO BIONICS HOLDINGS INC (NASDAQ), BIOMERICA INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), CARDIEX LTD (ASX), LIANLUO SMART LIMITED (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), COMPUMEDICS (ASX), STRATA SKIN SCIENCES INC (NASDAQ), YUNNAN ENERGY (HKEx), DAXOR CORP (NYSE American), OPTISCAN IMAGING (ASX), RESAPP HEALTH LIMITED (ASX), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), IMMUCELL CORP (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), TRUSCREEN GROUP LTD (ASX), APPLIED UV INC (NASDAQ), NOVA EYE MEDICAL LIMITED (ASX), DIMERIX LTD (ASX), MOTUS GI HOLDINGS INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), CELSION CORPORATION (NASDAQ), AETHLON MEDICAL INC (NASDAQ), OVENTUS MEDICAL LTD (ASX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), NEOVASC INC (NASDAQ), LBT INNOVATIONS LTD (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), LIFE HEALTHCARE (HKEx), NEUROTECH INTERNATIONAL LTD (ASX), METALICITY LIMITED (ASX), PREDICTIVE ONCOLOGY INC (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ), XTANT MEDICAL HLDGS INC (NYSE American), CHF SOLUTIONS INC (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), RA MEDICAL SYSTEMS INC (NYSE American), CYANOTECH CORP (NASDAQ), NANOVIBRONIX INC (NASDAQ), USCOM LTD (ASX), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), STAR EQUITY HOLDINGS INC (NASDAQ), DYNATRONICS CORP (NASDAQ), NEUROMETRIX INC (NASDAQ), CANCER GENETICS INC (NASDAQ), ADHERIUM LIMITED (ASX), OBALON THERAPEUTICS INC (NASDAQ), DORSAVI LTD (ASX), ANALYTICA (ASX), HUAKANG BIOMED (HKEx), INSPIREMD INC (NYSE American), MEDIGARD LIMITED (ASX), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days -+0.040
+3.70 %
10 Days -+0.120
+12.00 %
20 Days -+0.160
+16.67 %
Medium Term Return 3 Months --0.200
-15.15 %
6 Months 0.012+0.495
+81.12 %
1 Year 0.012+1.070
+2164.00 %
Long Term Return 2 Years 0.012+1.092
+3942.86 %
3 Years 0.012+1.072
+2258.33 %
5 Years 0.012+1.075
+2415.56 %
Annualised Return Annualised --
+90.60 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 0.048 - 1.980 Change From 1 Year Low +1.072 % Change From 1 Year Low (%) +2233.33
Change From 1 Year High -0.860 % Change From 1 Year High (%) -43.43
2 Years Range 0.022 - 1.980 Change From 2 Years Low +1.098 % Change From 2 Years Low (%) +4990.91
Change From 2 Years High -0.860 % Change From 2 Years High (%) -43.43
5 Years Range 0.022 - 1.980 Change From 5 Years Low +1.098 % Change From 5 Years Low (%) +4990.91
Change From 5 Years High -0.860 % Change From 5 Years High (%) -43.43
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

The Group's business started in 1989 with the incorporation of Clement Textile & International Corporation in Philippines in 1989. Medtecs is an integrated healthcare product and services provider in Asia Pacific, and a manufacturer and distributor of medical consumables for the healthcare industry. Started in the Philippines in 1989, the Group has established its presence in the United States, Europe and the Asia Pacific region. Today, the Group has offices in Singapore, Hong Kong, Taiwan, the Philippines, Cambodia and China.The Group is an original product manufacturer (OPM) of a wide range of medical consumables for large multinational healthcare distributors, pharmaceutical companies and hospital groups in the United States and Europe. Major product groups manufactured by the Group include linen, hospital apparel, hospital apparel and bandages. The Group’s OPM is supported by 10 manufacturing facilities located in the Philippines (4), China (4) and one each in Cambodia and Taiwan.The Group also acts as agent to distribute other branded medical devices in Asia Paci8fic, including medical supplies and equipment such as wheel chairs, syringes, gauzes, digital thermometers, nebulizers, blood pressure monitors and others.The Group’s Taiwan Depository Receipts (TDR) was listed on the Taiwan Stock Exchange on 13 December 2002.The Company is an investment holding company incorporated in Bermuda on 26 November 1997.

IPO Performance

Listing Date 06 Oct 1999 Full Subscription Rate (x) 10.99
No of Placement Shares (M) 27.00 No of Public Offer Shares (M) 18.00 Public Offer Subscription Rate (x) 25.98
IPO Price (SGD) a 0.251 First Day Close (SGD) a 0.334 First Week Close (SGD) a 0.328
Current vs IPO Price (%) +346.22 First Day Gain (%) +33.07 First Week Gain (%) +30.68
Notes:
  1. Adjusted for the following: Bonus issue 1 for 5 on 29/04/2004

Reports Download

Report Type Financial Year Ended Download
Annual Report
Annual Report 2019 Dec 2019 Part 1(5.04 MB)
Annual Report 2018 Dec 2018 Part 1(3.96 MB)
Annual Report 2017 Dec 2017 Part 1(3.57 MB)
Part 2(0.45 MB)
Annual Report 2016 Dec 2016 Part 1(2.67 MB)
Annual Report 2015 Dec 2015 Part 1(1.52 MB)
Annual Report 2014 Dec 2014 Part 1(4.00 MB)
Annual Report 2013 Dec 2013 Part 1(3.85 MB)
Annual Report 2012 Dec 2012 Part 1(3.68 MB)
Annual Report 2011 Dec 2011 Part 1(6.92 MB)
Annual Report 2010 Dec 2010 Part 1(3.56 MB)
Annual Report 2009 Dec 2009 Part 1(2.70 MB)
Annual Report 2008 Dec 2008 Part 1(1.48 MB)
Annual Report 2007 Dec 2007 Part 1(3.26 MB)
Part 2(0.02 MB)
Annual Report 2006 Dec 2006 Part 1(7.72 MB)
Annual Report 2005 Dec 2005 Part 1(23.76 MB)
IPO Prospectus
IPO Prospectus 1999 Oct 1999 Part 1(0.12 MB)
Part 2(0.39 MB)

Historical Price Data

Date Open High Low Close Volume VWAP
15 Jan 2021 1.130 1.140 1.110 1.120 8,023,600 1.1239
14 Jan 2021 1.130 1.140 1.100 1.100 7,380,900 1.1165
13 Jan 2021 1.090 1.140 1.090 1.120 12,738,000 1.1176
12 Jan 2021 1.080 1.100 1.070 1.080 6,549,900 1.0880
11 Jan 2021 1.100 1.120 1.070 1.080 16,260,300 1.0968
08 Jan 2021 1.050 1.100 1.040 1.080 18,030,500 1.0705
07 Jan 2021 1.040 1.050 1.030 1.050 2,781,000 1.0379
06 Jan 2021 1.060 1.060 1.030 1.030 5,840,500 1.0377
05 Jan 2021 1.030 1.080 1.030 1.050 15,480,800 1.0516
04 Jan 2021 1.020 1.040 1.000 1.020 7,949,900 1.0221
31 Dec 2020 1.010 1.020 1.000 1.000 3,092,400 1.0085
30 Dec 2020 1.010 1.040 1.000 1.000 7,063,800 1.0154
29 Dec 2020 1.010 1.020 0.990 0.995 5,560,300 1.0001
28 Dec 2020 1.050 1.060 1.010 1.020 4,324,700 1.0290
24 Dec 2020 1.070 1.070 1.020 1.050 6,171,100 1.0520
23 Dec 2020 1.070 1.100 1.050 1.050 11,035,000 1.0698
22 Dec 2020 1.000 1.070 1.000 1.040 22,646,000 1.0458
21 Dec 2020 0.975 1.010 0.970 0.995 9,654,500 0.9937
18 Dec 2020 0.970 0.980 0.960 0.960 3,077,400 0.9681
17 Dec 2020 0.960 0.975 0.955 0.960 2,749,700 0.9654
16 Dec 2020 0.970 1.000 0.955 0.955 7,472,700 0.9772
15 Dec 2020 0.935 0.975 0.925 0.970 7,082,500 0.9427
Summary
Current 2 Weeks
(04 Jan 2021 to 15 Jan 2021)
1.020 1.140 1.000 1.120 101,035,400 -
Previous 2 Weeks
(17 Dec 2020 to 31 Dec 2020)
0.960 1.140 0.955 1.000 75,374,900 -
4 Weeks from
(19 Nov 2020 to 16 Dec 2020)
0.930 1.140 0.915 0.955 210,790,800 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.